DUBLIN–(BUSINESS WIRE)–The “Global Virus Clearance Market (2022-2027) by Method, Product, Applications, End User, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis” report has been added to from ResearchAndMarkets.com offer.

The Global Virus Clearance Market is estimated at USD 532.9 Million in 2022 and is projected to reach USD 1,114.46 Million by 2027, growing at a CAGR of 15.9%.

Market segmentation

The global viral clearance market is segmented on the basis of method, product, applications, end-user, and geography.

• By method, the market is categorized into pasteurization and solvent detergent method.

• By product, the market is categorized into viral inactivation kits and reagents, services and systems and accessories.

• By Applications, the market is categorized into Blood & Blood Products, Cell & Gene Therapy Products, Stem Cell Products, Tissues & Tissue Products, and Vaccines & Therapeutics.

• By end-user, the market is categorized into academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies.

• By geography, the market is categorized into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Countries studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

• Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

The competitive quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and assess the position of companies based on their industry position score and market performance score. The tool uses various factors to classify players into four categories. Some of these factors considered for analysis are financial performance over the past 3 years, growth strategies, innovation score, new product launches, investments, market share growth, etc

Ansoff analysis

• The report presents a detailed analysis of the Ansoff matrix for the global viral clearance market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design business growth strategies. The matrix can be used to assess approaches in four strategies viz. Market development, market penetration, product development and diversification. The matrix is ​​also used for risk analysis to understand the risk associated with each approach.

• The global viral clearance market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its position in the market.

• Based on the SWOT analysis conducted on the industry and industry players, appropriate strategies have been devised for market growth.

Why buy this report?

• The report offers a comprehensive assessment of the global viral clearance market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and market size projections. Projections are calculated using proven research methodologies.

• The report has been compiled through extensive primary and secondary research. Primary research is done through interviews, surveys and observations of renowned personnel within the industry.

• The report includes in-depth market analysis using Porter’s 5 forces model and Ansoff’s matrix. Additionally, the impact of COVID-19 on the market is also presented in the report.

• The report also includes the regulatory scenario within the industry which will help you to make an informed decision. The report discusses the major regulatory bodies and major rules and regulations imposed on this industry across various geographies.

• The report also contains competitive analysis using “positioning quadrants”; a proprietary competitive positioning tool.

Market dynamics

Drivers

• Growing government support for the pharmaceutical and biotech industries

• Possibility of cell culture contamination

• Increase in the prevalence of chronic diseases

• Growing number of new drug launches

Constraints

• High costs associated with manufacturing biosimilars

• Time-consuming drug development process

Opportunities

• Increase in pharmaceutical outsourcing

• Strong R&D investments in the life sciences industry

Challenges

• Shortage of qualified professionals

• High degree of consolidation to act as a major barrier for new entrants

Main topics covered:

1 Description of the report

2 Research methodology

3 Executive summary

4 Market dynamics

5 Market Analysis

6 Global Virus Clearance Market, By Method

7 Global Virus Clearance Market, By Product

8 Global Virus Clearance Market, by Applications

9 Global Virus Clearance Market, By End User

10 Americas Viral Clearance Market

11 European viral clearance market

12 Middle East & Africa Viral Clearance Market

13 APAC Viral Clearance Market

14 Competitive landscape

15 company profiles

16 Appendix

Companies cited

• Agilent Technologies, Inc.

• Advance Biosciences Inc.

• Becton, Dickinson and Co.

• Bio-Rad Laboratories, Inc.

• Charles River International Laboratories, Inc.

• Clean cells inc.

• Danaher Corp.

• Eppendorf SE

• Eurofins Scientific SE

• F. Hoffmann-La Roche Ltd.

• General Electricity Company.

• HiMedia Laboratories

• Lonza Group AG

• Merck Group

• Novogene Co. Ltd.

• Parker Hannifin Corp.

• Pfizer Inc.

• PromoCell GmbH

• RadSource Technologies, Inc.

• Sartorius AG

For more information on this report, visit https://www.researchandmarkets.com/r/f091w9